Summary:
Do you have acute migraines?
If so, you may qualify for a randomized, double-blind, single-dose, placebo-controlled study to assess the efficacy and safety of an investigational medication for the acute treatment of migraine in adults with inadequate response to prior acute treatments.
Qualified Participants Must:
• Be male or female ages 18 to 65
•
Have a history of episodic migraine for at least 1 year
•
Have 2 to 8 migraine attacks per month
•
Have had inadequate response to prior acute treatments
Qualified Participants May Receive:
Compensation for time and travel.